Intraocular Melanoma Completed Phase 1 / 2 Trials for Sargramostim (DB00020)

Also known as: Intraocular melanoma NOS

IndicationStatusPhase
DBCOND0028574 (Intraocular Melanoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00089219Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV MelanomaTreatment